Butler Snow’s Pharmaceutical, Medical Device and Healthcare practice group kicked off 2023 with a trial win in a pelvic mesh case involving a 56-year-old woman seeking more than $12 million in damages. The Butler Snow team worked alongside partnering counsel, Orrick and Squire Patton Boggs, to achieve a complete defense verdict in Hudspeth v. Ethicon.
Butler Snow attorney Susanna Moldoveanu served as appellate trial counsel, with Adam Porter serving as attorney trial support. In addition, Bonnie Tuten, Haley Hard, and Amber Alexander all served as paralegal support.
This verdict came after an 8-day trial. After a two-hour deliberation, the jury concluded that the product in question was not defective, resulting in a complete defense verdict. This win represents the ninth straight win for Butler Snow in less than a year, after achieving an undefeated record in 2022 with eight straight defense verdicts.
We congratulate our team on their exceptional work in this case and look forward to more trial victories in 2023.
Butler Snow’s Pharmaceutical, Medical Device and Healthcare Industry practice group provides clients with a comprehensive, multidisciplinary legal team to minimize legal exposure, litigate through resolution, and handle crisis management. Few firms in the United States have been called upon as often as this firm to serve as local, regional or national counsel in significant pharmaceutical, medical device and healthcare cases. The firm’s litigators play leading roles in federal multi-district proceedings and try a broad range of cases, including bellwether cases. Butler Snow attorneys are experienced in responding to complex regulatory, compliance and policy challenges. The firm’s litigators have tried cases to verdict in state and federal courts and on appeal in virtually every state and numerous foreign countries. Butler Snow regularly leads trial teams in some of the most challenging jurisdictions in the country with significant experience navigating complex cases involving a broad array of products and medical devices brought by single plaintiffs and more often class actions, involving anywhere from hundreds to thousands of plaintiffs.
